Air Sanitation Manufacturer AeroClean Technologies Prices US$25 Million IPO

Pathogen elimination technology company AeroClean Technologies, Inc. (Nasdaq: AERC) started publicly trading on the Nasdaq Capital Market today. The firm’s initial public offering is looking to raise US$25 million.

The offering will be conducted through the issuance of 2.5 million common shares selling at US$10.00 per share.

The Benchmark Company, HCFP/Capital Markets, and Valuable Capital Limited are all acting as joint bookrunners for the said offering.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

The firm relayed that net proceeds from the offering are expected to be used on supporting the build-out of its organization, funding its air purification devices production, establishing a consumables and services business, and supporting its product development efforts.

The company manufactures air sanitation products and provides anti-pathogen solutions. Its flagship product Pūrgo is developed with a proprietary technology designed by aerospace engineers and medical scientists.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Building the $500M-a-Year Gold Mine | Victor Cantore – Amex Gold Mining

Building the Next 500,000-Ounce Gold Producer | Stephen Soock – Heliostar Metals

This Gold Explorer Is Making Its Biggest Bet | Brian Miller – Astra Exploration

Recommended

This Gold Discovery Just Keeps Getting Bigger | Roger Rosmus – Goliath Resources

Cardiol Expands MAVERIC Trial to Up to 150 Patients After Reaching Enrollment Target Early

Related News

Holtec IPO Poised At $10B, Could Be Nuclear’s Largest

Holtec International has filed confidentially with the SEC to go public, positioning what could be...

Monday, February 16, 2026, 08:46:00 AM

Biotech Firm IN8bio Eyes US$40 Million IPO

Clinical-stage biopharmaceutical company IN8bio, Inc. (Nasdaq: INAB) began trading on the Nasdaq Global Market today...

Friday, July 30, 2021, 11:56:00 AM

Tech SPAC Yotta Acquisition Prices US$100 Million IPO

Special purpose acquisition company Yotta Acquisition Corporation (Nasdaq: YOTAU) started trading its securities on the...

Wednesday, April 20, 2022, 02:23:00 PM

Biotech Firm PepGen Prices US$108 Million IPO

Biopharmaceutical company PepGen, Inc. (Nasdaq: PEPG) began trading on the Nasdaq Global Select Market on...

Monday, May 9, 2022, 02:27:00 PM

Ex-Sony Entertainment CEO-Led Gaming SPAC PowerUp Acquisition Prices Upsized US$250 Million IPO

Special purpose acquisition company PowerUp Acquisition Corp (Nasdaq: PWUPU) started trading publicly on the Nasdaq...

Friday, February 18, 2022, 02:26:00 PM